Biolase EBITDA Margin 2010-2023 | BIOL

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Biolase (BIOL) over the last 10 years. The current EBITDA margin for Biolase as of December 31, 2023 is .
Biolase EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $0.05B $-0.01B -29.17%
2023-09-30 $0.05B $-0.02B -34.69%
2023-06-30 $0.05B $-0.02B -42.00%
2023-03-31 $0.05B $-0.02B -50.00%
2022-12-31 $0.05B $-0.02B -47.92%
2022-09-30 $0.05B $-0.02B -43.48%
2022-06-30 $0.04B $-0.02B -34.09%
2022-03-31 $0.04B $-0.01B -31.71%
2021-12-31 $0.04B $-0.02B -38.46%
2021-09-30 $0.04B $-0.02B -44.44%
2021-06-30 $0.03B $-0.02B -51.52%
2021-03-31 $0.03B $-0.02B -66.67%
2020-12-31 $0.02B $-0.02B -70.83%
2020-09-30 $0.03B $-0.02B -60.00%
2020-06-30 $0.03B $-0.02B -62.96%
2020-03-31 $0.03B $-0.02B -48.48%
2019-12-31 $0.04B $-0.02B -39.47%
2019-09-30 $0.04B $-0.02B -43.90%
2019-06-30 $0.04B $-0.02B -39.53%
2019-03-31 $0.05B $-0.02B -39.13%
2018-12-31 $0.05B $-0.02B -41.30%
2018-09-30 $0.05B $-0.02B -36.96%
2018-06-30 $0.05B $-0.02B -36.96%
2018-03-31 $0.05B $-0.02B -36.17%
2017-12-31 $0.05B $-0.02B -33.33%
2017-09-30 $0.05B $-0.02B -32.65%
2017-06-30 $0.05B $-0.02B -29.41%
2017-03-31 $0.05B $-0.01B -26.92%
2016-12-31 $0.05B $-0.01B -26.92%
2016-09-30 $0.05B $-0.01B -22.64%
2016-06-30 $0.05B $-0.01B -27.45%
2016-03-31 $0.05B $-0.02B -36.73%
2015-12-31 $0.05B $-0.02B -38.78%
2015-09-30 $0.05B $-0.02B -44.68%
2015-06-30 $0.05B $-0.02B -38.78%
2015-03-31 $0.05B $-0.02B -38.30%
2014-12-31 $0.05B $-0.02B -35.42%
2014-09-30 $0.05B $-0.02B -30.00%
2014-06-30 $0.05B $-0.02B -32.65%
2014-03-31 $0.05B $-0.01B -22.64%
2013-12-31 $0.06B $-0.01B -19.64%
2013-09-30 $0.06B $-0.01B -13.33%
2013-06-30 $0.06B $-0.00B -6.45%
2013-03-31 $0.06B $-0.00B -6.67%
2012-12-31 $0.06B $-0.00B -3.51%
2012-09-30 $0.05B $-0.01B -9.80%
2012-06-30 $0.05B $-0.01B -12.00%
2012-03-31 $0.05B $-0.01B -10.00%
2011-12-31 $0.05B $-0.00B -8.16%
2011-09-30 $0.05B $-0.00B -2.17%
2011-06-30 $0.04B $-0.00B -5.13%
2011-03-31 $0.03B $-0.01B -15.15%
2010-12-31 $0.03B $-0.01B -38.46%
2010-09-30 $0.03B $-0.01B -46.15%
2010-06-30 $0.03B $-0.01B -28.13%
2010-03-31 $0.04B $-0.00B -5.00%
2009-12-31 $0.04B $-0.00B -4.65%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.005B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62